MintNeuro Raises £1M to Revolutionize Neural Implants with Semiconductor Tech

MintNeuro, a London-based healthcare technology firm, has successfully secured a £1 million investment round led by Empirical Ventures, with contributions from Parkwalk Advisors, Imperial College London, Plug & Play, Excellis Holding, and key angel investors. This funding will accelerate the development of MintNeuro's innovative semiconductor technology for neural implants, poised to address the significant global burden of neurological disorders. Traditional treatments often fall short due to limitations in current neural implant technologies, which are typically bulky and invasive. However, MintNeuro, a spinout from Imperial College London, is pioneering scalable, low-power semiconductor technology for minimally invasive applications in neural treatment. With over £14 million already garnered in R&D, the company aims to enhance the accessibility of these devices by making them smaller and more efficient. The investment will facilitate MintNeuro's collaboration on projects like the NIHR-funded DREAM initiative for epilepsy monitoring and a partnership with Amber Therapeutics to develop neuromodulation therapy. Given the global neural implant market's rapid growth, MintNeuro's innovations promise to transform treatment options for conditions such as Parkinson's, dementia, and depression, offering a scalable solution to the healthcare industry.